4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells NVLycoVITnWwY4Tpc44h[XO|YYm= MUjB[49vcXO2aXOgZYN1cX[rdImge4F{KGSndHXycYlv\WRiaX6gR29UOSClZXzsd{B1emGwc3\lZ5Rm\CC5aYToJGdCVCB2LWDQRXIh\2GvbXGgdoVk\XC2b4KsJGVEPTB;MD6wNlEh|ryP MVqxNlYyPzl{NB?=
CV-1 cells MmWzSpVv[3Srb36gZZN{[Xl? M1jCWW1igGmvYXygdoVxd3K2ZYKgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSZYLvfIl{d22nIIDyc4xq\mW{YYTvdkBi[3SrdnH0[YQhemWlZYD0c5Ih\2GvbXGgS4FtPCClaHnt[ZJq[yCrbjD0doFve2mnboTsfUB1emGwc3\lZ5Rm\CCFVj2xJINmdGy|IHL5JIZ2dmO2aX;uZYwh[XO|YYmsJGVEPTB;MD6wOFMh|ryP M{W5blEyPzJyOEW0
COS-1 cells NVnkO|FQTnWwY4Tpc44h[XO|YYm= MlLuTY4hfmm2cn:geJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIIDldo95cXOxbXWgdJJwdGmoZYLheI9zKGGldHn2ZZRm\CC{ZXPldJRweiCpYX3tZUBu\WG|dYLl[EBqdiCSUFHSMWdCVDRiY3jpcYVzcWNiQ1;TMVEh[2WubIOsJGVEPTB;MD6wNkDPxE1? MWOxNlg4OzVzNx?=
CV-1 cells NWnHSXdLTnWwY4Tpc44h[XO|YYm= NUnBNopYSWO2aY\heIlwdiCxZjDw[ZJwgGm|b33lJJBzd2yrZnXyZZRweiCjY4TpeoF1\WRicnXj[ZB1d3JiZ3HtcYEhdWWjc4Xy[YQh[nliaX7keYN1cW:wIH;mJFUxLSCxZjDtZZhqdXWvIHHsb4FtcW6nIIDoc5NxcGG2YYPlJIFkfGm4aYT5MEB1emGwc3\lZ5Rqd25iYYPzZZkhcW5iQ2[tNUBk\WyuczygSWM2OD1yLkC4PVE{KM7:TR?= MXS5PFM3PjJy
CV-1 cells NXXoenJkTnWwY4Tpc44h[XO|YYm= MYLJckB3cXS{bzD0doFve2O{aYD0bY9v[WxiYXP0bZZifGmxbjDv[kBR\XKxeHnzc41mKHC{b3zp[oVz[XSxcjDhZ5RqfmG2ZXSgdoVk\XC2b4Kg[4FudWFiKGDQRXIqKGW6cILld5Nm\CCrbjDDWk0yKGOnbHzzMEBGSzVyPUCuNFYh|ryP NFvQ[XM5PTd4OUC3
COS-1 cells NF3YfG5HfW6ldHnvckBie3OjeR?= MV\JckB3cXS{bzDh[49vcXO2IHHjeIl3cXS7IITld5Rm\CCob4KgeJJidnOjY4TpeoF1cW:wIHnuJIh2dWGwIGDQRXIh\2GvbXGtS4FtPCClaHnt[ZJq[yCFT2OtNUBk\WyuczygSWM2OD1yLkCyJO69VQ>? MXixNlczQTZ4OB?=
CV-1 cells M1ztOmZ2dmO2aX;uJIF{e2G7 MYjJckB3cXS{bzDleoFtfWG2aX;uJIFo[Wmwc4SgVnhTNWGucHjhM3BRSVJvZ3HtcYEhcW5iQ2[tNUBk\WyuczDifUBkd3S{YX7z[oVkfGmxbjDhd5NigSC5YYOg[IV1\XKvaX7l[EwhTUN3ME2wMlMzPSEQvF2= NVHa[3dbOTJ7NUSwOlE>
HepG2 cells M{LoXmZ2dmO2aX;uJIF{e2G7 NYW3[Fg2TW[oZXP0bZZmKGOxbnPlcpRz[XSrb36gZYdicW6|dDDoeY1idiCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhmeEd{IHPlcIx{NCCHQ{WwQVAvODN7IN88US=> M1TnRVE3OTB5MUWw
Huh7 cells MlX6SpVv[3Srb36gZZN{[Xl? MXTGeY5kfGmxbnHsJIFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> M3rvTFE3OzZ4NkCx
Huh7 cells MnP2SpVv[3Srb36gZZN{[Xl? NVGzUo9FTW[oZXP0JI9vKFCSQWKg[4FudWFidILhcpNi[3SrdnH0bY9vKGGldHn2bZR6KGmwIFj1bFch[2WubIOsJGVEPTB;MD6yNkDPxE1? MWWxOlQ2OTB6Nx?=
U2OS cells M4SxdGZ2dmO2aX;uJIF{e2G7 NWThc4pKTW[oZXP0JI9vKFCSQWLnZY1u[SC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkhcW5iVULPV{Bk\WyuczygSWM2OD1yLkCzJO69VQ>? MVSxOlMxODl2NB?=
CV1 cells MWLGeY5kfGmxbjDhd5NigQ>? NVH1dWdQXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWLnZY1u[SCrbjDDWlEh[2WubIOsJGVEPTB;MD6wO|Yh|ryP MYqxOlgzOTd4OR?=
human keratinocytes MVrQdo9tcW[ncnH0bY9vKGG|c3H5 MmfoRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCtZYLheIlvd2O7dHXzMEBGSzVyPUig{txO MUKxOlgzOTd4OR?=
HT29 cell MXPQdo9tcW[ncnH0bY9vKGG|c3H5 M{LIRWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGSyPUBk\WyuIHzpcoUtKEWFNUC9OFUh|ryP NYDFRnppOTZ6MkG3Olk>
NIH3T3 cells NXj3bHlTTnWwY4Tpc44h[XO|YYm= NHX4SG5C[3Srdnn0fUBifCCqdX3hckBRWEGUIHfhcY1iKHS{YX7z[oVkfGWmIHnuJG5KUDOWMzDj[YxteyCkeTDseYNq\mW{YYPlJIFkfGm4aYT5JIF{e2G7LDDFR|UxRTBwM{Kg{txO NYnNXHJVOTZ6NUSwPFU>
CV1 cells M2XRSGZ2dmO2aX;uJIF{e2G7 NXLUNnhVXHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOzB6IN88US=> M1vCZVE3QTdyM{mx
Huh7 cells M1rKWmZ2dmO2aX;uJIF{e2G7 NXm4[od5SWO2aY\peJkh[XRiaIXtZY4hWFCDUjDnZY1u[SCrbjDIeYg4KGOnbHzzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkKyJO69VQ>? NWLVeW5kOTdyM{SxOFk>
HepG2 cells NGSyTYlHfW6ldHnvckBie3OjeR?= M1KySGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWiCpYX3tZUBqdiCjIFjldGczKGOnbHzzJIJ6KFCSQWKtS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6xOVgh|ryP M3vPfVE3QTd|M{W4
HepG2 cells Mn3YSpVv[3Srb36gZZN{[Xl? NGTvWmZC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSHXwS|Ih[2WubIOgZpkhWFCDUj3HRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG1PO69VQ>? MWmxOlk4QTN2MR?=
CV1 cells M4HvOGZ2dmO2aX;uJIF{e2G7 MVvBZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hS1ZzIHPlcIx{NCCHQ{WwQVAvOzB6IN88US=> M3vMe|E4ODB3M{m0
HEK293 cells MVPGeY5kfGmxbjDhd5NigQ>? Ml7BRYN1cX[rdImgZZQhcHWvYX6gZYRqeG:|ZTD0bZN{fWViUGDBVkBo[W2vYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JHBRSVJvR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5|MTFOwG0> MVGxO|M1OzN5MR?=
rat L6 cells MYjGeY5kfGmxbjDhd5NigQ>? M2WzOGVn\mWldDDvckBn[XS2eTDhZ4llKG:6aXTheIlwdiCrbjDyZZQhVDZiY3XscJMtKEWFNUC9OUDPxE1? NFzEVpcyPzN2M{O3NS=>
HepG2 cells MWjGeY5kfGmxbjDhd5NigQ>? MlrWRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hUGWyR{KgZ4VtdHNiYomgVHBCWi2JQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB6MjFOwG0> MUCxO|E2PzBzOR?=
CV1 cells M37pT2Z2dmO2aX;uJIF{e2G7 MVrB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJidHCqYTDpckBEXjFiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XliYX\0[ZIhOjRiaILzMEBGSzVyPUOuOFYh|ryP NED4UGgyPzVyN{KyOS=>
CV1 cells MkLvSpVv[3Srb36gZZN{[Xl? NY\u[5Y4SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5JIFnfGW{IEK0JIhzeyxiRVO1NF0xNjB|IN88US=> NUKz[WtyOTd3MEeyNlU>
CV1 cells MYfGeY5kfGmxbjDhd5NigQ>? M2[5VGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCFVkGgZ4VtdHNiYomgdoVk\XC2b4KgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOzB6IN88US=> Ml7FNVgxOjlzN{i=
CV1 cells M3vZWWZ2dmO2aX;uJIF{e2G7 NIHDWodC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDDWlEh[2WubIOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwM{C4JO69VQ>? NHHWOm0yPzF{OUeyOS=>
HEK293 cells NHfqU3NHfW6ldHnvckBie3OjeR?= NWLFZZhWSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCzOUDPxE1? MVWxO|I6OjZyNh?=
NIH3T3 cells NVz2bnoxTnWwY4Tpc44h[XO|YYm= M3LrdGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCQSVizWFMh[2WubIOgZpkhT0GONDD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4{OiEQvF2= MUKxO|YzPDd5Nx?=
HEK293 cells MnfsSpVv[3Srb36gZZN{[Xl? NVXOV|RsSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG5JO69VQ>? MYCxPFAzQTF5Nh?=
HEK293 cells MkGxSpVv[3Srb36gZZN{[Xl? Mm\aRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bie3Onc4Pl[EBieyCjUEKg[4Vv\SCrbnT1Z5Rqd25uIFXDOVA:OC5zMjFOwG0> MVKxPFAzQTF5Nh?=
HEK293 cells MoOwSpVv[3Srb36gZZN{[Xl? NIHPe5hC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDISWszQTNiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yNEWg{txO MV:xPFI6OTZ2NR?=
HepG2 cells M3fvWmZ2dmO2aX;uJIF{e2G7 MVfB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJidHCqYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHj1cYFvKEincFeyJINmdGy|IHPvMZRz[W6|ZnXjeIVlKHerdHigS4FtPCCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOzlizszN M1LaWlE5QDN3N{G5
RAW264.7 cells M1r0PWZ2dmO2aX;uJIF{e2G7 M{\lfnN2eHC{ZYPzbY9vKG:oIFzQV{9KTk5vZ3HtcYEue3SrbYXsZZRm\CCQTzDwdo9lfWO2aX;uJIlvKG2xdYPlJHJCXzJ4ND63JINmdGy|LDDFR|UxRTF5LkWg{txO MYexPFgxQTN{NR?=
BL21 cells MYXGeY5kfGmxbjDhd5NigQ>? NFTse4dFcXOybHHj[Y1mdnRib3[gdoFlcW9ibHHi[Yxm\CB{KGOpMUgzNWKnborvfYwueGinbonsZY1qdm9rLUOtf|QuYzFuMT3kbZRzcXSrbz2yMUg2NW2ndHj5cE0zNXCqZX75cE1wgGG8b3ytOE16dClvZYToc5h6ZS2yaHXufYx:NXC{b4Dpc45q[yCjY3nkJIZzd21iR2PUMYZ2e2WmIHj1cYFvKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gSZNkcGW{aXPobYEh[2:uaTDCUFIyKGOnbHzzJIJ6KHOlaX70bYxt[XSrb36gdJJwgGmvaYT5JIF{e2G7LDDFR|UxRTBwNEWg{txO MoLsNVk{PDlzN{[=
BHK21 cells MXPGeY5kfGmxbjDhd5NigQ>? M3PjdWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCESFuyNUBk\WyuczDhd5Nme3OnZDDhd{BUTUGSIHHjeIl3cXS7IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwNEWg{txO NWTjeY5EOTl|NEmxO|Y>
HepG2/C3A cells M4TufmZ2dmO2aX;uJIF{e2G7 M1;MZmFkfGm4YYTpc44hd2ZiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbj3t[YRq[XSnZDD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliaX6gbJVu[W5iSHXwS|IwSzODIHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiZoXz[YQhT2GuND3MRmQh[nliY3;0doFve2[nY4Tpc44h[XO|YYmsJGVEPTB;MD6wNFM5KM7:TR?= NUHKbHlJOTd2MEO2PFg>
HepG2 cells NWiyXZdiTnWwY4Tpc44h[XO|YYm= MYrB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKHKnY3XweI9zKHS{YX7zZYN1cX[jdHnvckBjgSC{ZYDvdpRmeiCpZX7lJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3ysJGVEPTB;MD6wOUDPxE1? MYexPFYzPTV3OR?=
COS1 cells MVHGeY5kfGmxbjDhd5NigQ>? MXLB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iQ1;TNUBk\WyuczDjc{1mgHC{ZYPzbY5oKEeDTESgZZN{\XO|ZXSgZZMhfHKjboPjdolxfGmxbnHsJIFkfGm4aYT5JIFnfGW{IES4JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOiEQvF2= MVqxPVUxPzh4MR?=
HepG2 cells NGTk[HhHfW6ldHnvckBie3OjeR?= NVfZS3U2SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOjJ|IN88US=> NIHDXFIyQDN7NEmwOy=>
CV1 cells MX3GeY5kfGmxbjDhd5NigQ>? MUHB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNXOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKG[3c3XkJGdidDRvRFLEJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCzN{DPxE1? MkjlNVg5OjZ{MEW=
CV1 cells MXrGeY5kfGmxbjDhd5NigQ>? MoH0RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT[WyyaHGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDh[pJq[2GwIHfy[YVvKG2xbnvlfUBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVTCSEBjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;Mz60OkDPxE1? Mm\5NVg5OjZ{MEW=
U2OS cells MmHLSpVv[3Srb36gZZN{[Xl? NXy4VIRSSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iVULPV{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMjFOwG0> NXLtXpAyOTh|Mkm3OVE>
Hep G2 cells MWrGeY5kfGmxbjDhd5NigQ>? MVnB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHj1cYFvKEincDDHNkBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRvRFLEJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC0JO69VQ>? Mmf4NVkxPTN5N{[=
HeLa cells MWnGeY5kfGmxbjDhd5NigQ>? M3ixS2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVN[SClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbEStSGJFKGG|c3Xzd4VlKGG|IITyZY5{[3KrcITpc45idCCjY4TpeoF1cW:wIHL5JGdidDRicnXzdI9ve2ViZXzlcYVvfC2mcnn2[Y4hdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEG1JO69VQ>? Mn3rNVkzPzV7NkO=
COS1 cells MkPSSpVv[3Srb36gZZN{[Xl? M4jjVmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3MyKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIgh\nW|ZXSgfYVie3RiR3HsOE1FSkRiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODJizszN MlTENVk2OzB4OEG=
U2OS cells NUTlfJgxTnWwY4Tpc44h[XO|YYm= MV7B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hXTKRUzDj[YxteyCkeTDseYNq\mW{YYPlJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB3IN88US=> NGfhcogyQTV5NEC1Oi=>
HepG2 cells MWDGeY5kfGmxbjDhd5NigQ>? NY\RcZhNSWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MZRi\2enZDDoeY1idiCSUFHS[4FudWFibHnnZY5lKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCjc4Pld5Nm\CCjczDy[YNmeHSxcjD0doFve2GldHn2ZZRqd25iYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODN7IN88US=> M1PzRlE6Pzd3MU[5
HepG2 cells NFK2OlNHfW6ldHnvckBie3OjeR?= MoX6RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEincFeyJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNlI{KM7:TR?= MmK5NVk4QDN2NES=
COS7 cells MmXUSpVv[3Srb36gZZN{[Xl? MWXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHBRSVKpYX3tZVIhVEKGIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFT2O3JINmdGy|IHPv[ZhxemW|c3nu[{BISUx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4yKM7:TR?= NVK0Xmp4OjBzM{i3OlI>
COS7 cells NFLxcGtHfW6ldHnvckBie3OjeR?= MX3B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHBRSVKpYX3tZVEhVEKGIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFT2O3JINmdGy|IHPv[ZhxemW|c3nu[{BISUx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOyEQvF2= NFrxUnozODF|OEe2Ni=>
HEK cells NIHQOXJHfW6ldHnvckBie3OjeR?= NXzvRXNoSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LYTh[4dm\CCSUFHSZYxxcGFiY3jpcYVzcWNicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUyClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MUCuOVgh|ryP MYOyNFI6QTJzNB?=
HEK cells NEn3VGhHfW6ldHnvckBie3OjeR?= NFTvV3RC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJGdCVDRvdHHn[4VlKFCSQWLnZY1u[SClaHnt[ZJq[yC{ZXPldJRweiCneIDy[ZN{\WRiaX6gTGVMKGOnbHzzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCzOUDPxE1? NEHvWoYzODJ7OUKxOC=>
3T3L1 cells MWrGeY5kfGmxbjDhd5NigQ>? M1z2NFch\GG7cx?= NUKyTpFMUW6mdXP0bY9vKG:oIHHkbZBw\2WwZYPpd{BqdiCvb4Xz[UA{XDOOMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBtcXCrZDDhZ4N2dXWuYYTpc44h[W[2ZYKgO{Bl[Xm|IHL5JG9qdCC{ZXSgU{B{fGGrbnnu[y=> M1nxOVIxPTJ5OU[5
CHO-K1 cells MYHGeY5kfGmxbjDhd5NigQ>? M2PGV3BienSrYXygZYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGtUGJFKGW6cILld5Nm\CCrbjDDTG8uUzFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCJQVy0JIF{e2W|c3XkJIF{KGy3Y3nm[ZJie2ViYXP0bZZqfHliYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOSEQvF2= M3j5SFIxPTJ5OU[5
HEK293T cells MmjHSpVv[3Srb36gZZN{[Xl? MX6xJO69VQ>? M2fVdFI1KGi{cx?= M1HIZ3BienSrYXygZYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGtUGJFKGW6cILld5Nm\CCrbjDISWszQTOWIHPlcIx{KGG|c3Xzd4VlKGG|IHnu[JVkfGmxbjDv[kBz\WOncITvdkB1emGwc3HjeIl3[XSrb36gZZQhOSC3TTDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 MlHPNlExOzB{NkO=
CV1 cells NV3zUVg3TnWwY4Tpc44h[XO|YYm= NEHpZohVemGwc3HjeIl3[XSrb36gc4YhT2GuND3meZNm\CCqdX3hckBRWEGUZ3HtcYEhTE6DIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDh[pJq[2GwIHfy[YVvKG2xbnvlfUBEXjFiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNUDPxE1? MnfPNlEyOTJ5OES=
HEK293 cells NWf1Xoh2TnWwY4Tpc44h[XO|YYm= NFvLPFEyPiC2bzCyNEBpenN? NELMOllVemGwc3HjeIl3[XSrb36gc4YhT2GuND3meZNm\CCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bi\nSncjCxOkB1dyB{MDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFQ{KM7:TR?= NYrTSXpNOjFzMki2NFA>
HepG2 cells MXTGeY5kfGmxbjDhd5NigQ>? M4HVNFExKHWvb3yvUC=> NFyxXIMzPCCqcoO= MlnWTY5kemWjc3WgbY4h\2y3Y3;z[UBkd26|dX3weIlwdiCrbjDoeY1idiCKZYDHNkBk\WyuczDheEAyOCC3bX;sM2wh[W[2ZYKgNlQhcHK|IILlcIF1cX[nIITvJINwdnS{b3y= MWeyNVI2Pjd2OB?=
3T3L1 cell NXnLU29tTnWwY4Tpc44h[XO|YYm= NIjtVmoyKHWP MWTJcoR2[3Srb36gc4YhdW:3c3WgN3Q{VDFiY3XscEBlcW[oZYLlcpRq[XSrb36gZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iYXPjeY12dGG2aX;uJI9nKGmwdILhZ4VtdHWuYYKgcIlxcWRiZILvdIxmfCCjdDCxJJVOKGK7IF;pcEBz\WRiTzDzeIFqdmmwZx?= MonHNlE1ODFzMUi=
CV1 cells MnfFSpVv[3Srb36gZZN{[Xl? M325cFQxKGh? NGLBW4FC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZU1NSkRiZYjwdoV{e2WmIHnuJGNXOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbESgZYZ1\XJiNECgbJJ{KGK7IHz1Z4ln\XKjc3WgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNUDPxE1? M325TlIyPTF3ME[z
HepG2 cells NVL4eXB{TnWwY4Tpc44h[XO|YYm= MWrB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBz\WOncITvdkBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgVHBTTS2udXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wNUDPxE1? M1rmfFIyPDh{NES2
HepG2 cells MWrGeY5kfGmxbjDhd5NigQ>? Mn\HWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCSUGLFN{1VUy2OdXOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEWg{txO NWDEemFbOjF2NUC0Olg>
COS7 cells MnLJSpVv[3Srb36gZZN{[Xl? NYrUdJdEVW:mdXzheIlwdiCxZjDoeY1idiCSUFHS[4FudWFvTFLEJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3M4KGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT2GuNDDhd5Nme3OnZDDhd{Bi[3SrdnH0bY9vKG:oIITyZY5{[WO2aY\heIlwdiCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJIF{e2G7LDDFR|UxRTBwMESzJO69VQ>? M{\Ec|IyQDd|MEew
COS-1 cells MlrDSpVv[3Srb36gZZN{[Xl? NVPkc5JpOjRiaILz NEfxboRC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGNQWy1zIHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWtZoF{\WRibIXtbY5wdWW2cnnjJIFv[Wy7c3nzMEBGSzVyPUCuNFQ5KM7:TR?= MVKyNlA2OTB3NB?=
COS1 cells M4K3XmZ2dmO2aX;uJIF{e2G7 NITDUVAzPCCqcoO= MX;UdoFve2GldHn2ZZRqd25ib3[gbJVu[W5iZoXscEBt\W6pdHigVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCFT2OxJINmdGy|IHPvMZRz[W6|ZnXjeIVlKHerdHigVnhT[WyyaHGgZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlEzKM7:TR?= NX[4O3FXOjJzOUezPVY>
MG-63 cells MVrGeY5kfGmxbjDhd5NigQ>? NXj1eGdiSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIF3HMVY{KGOnbHzzJIJ6KHKncH;yeIVzKGenbnWtZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFEyKM7:TR?= M2rlVFIzOjJ3NkSx
COS1 cells MWfGeY5kfGmxbjDhd5NigQ>? M1f3XWJqdmSrbnegZYZncW6rdImgeI8hcHWvYX6ge4lt\CC2eYDlJHBRSVKpYX3tZUBNSkRiZYjwdoV{e2WmIHnuJGNQWzFiY3XscJMh[29vZYjwdoV{e2mwZzDHRWw1KGK7IIPjbY51cWyuYYTpc44heHKxeHntbZR6KGG|c3H5 M4O5RlIzODdyNkC0
MG-63 cells MXXGeY5kfGmxbjDhd5NigQ>? NYrJXnBoOjRiaILz MYTNc4R2dGG2aX;uJI9nKG[3bHytcIVv\3SqIHj1cYFvKHCVR{Wt[pV{\WRiUGDBVodidW2jIHX4dJJme3OnZDDpckBOTy14MzDj[YxteyClbz3lfJBz\XO|aX7nJJBIXi2SMj3QVHJGKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFEyKM7:TR?= M3HiVVIzPzJ5NES4
Ac2F cells NFTqPXBHfW6ldHnvckBie3OjeR?= NWL3b5N2OC5zIITvJFExKM7:TR?= M4DyU|YhcHK| NWnScVZ4SWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiaX6gdoF1KEGlMl[gZ4VtdHNiYYPz[ZN{\WRiYYOgcJVkcW[ncnHz[UBi[3Srdnn0fUBifCByLkGgeI8hOTBidV2gZYZ1\XJiNjDodpMh[nlicnXwc5J1\XJiZ3Xu[UBie3OjeR?= M1\uVVIzQDF7MUmw
293H DA cells MXfGeY5kfGmxbjDhd5NigQ>? MXGxOkBp Mmn5RYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhVEKGIHnuJIh2dWGwIEK5N2ghTEFiY3XscJMh[W[2ZYKgNVYhcHK|IHL5JHRTNU[URWSgZYN1cX[jdHnvckBz\XCxcoTldkBie3OjeTygSWM2OD1yLkCwNlQh|ryP NYrLenVQOjJ3OEK5O|M>
3T3L1 cells M1nBW2Z2dmO2aX;uJIF{e2G7 M2WxT|ExKHWP MX;JcoNz\WG|ZTDpckBi\Gmyb37lZ5RqdiCvUl7BJIxmfmWuczDpckBVVk[jbIDoZU1qdmS3Y3XkJI1wfXOnIEPUN2wyKGOnbHzzJJBz\XS{ZXH0[YQh[XRiMUCgeW0h[mWob4LlJHRPTi2jbIDoZUBkcGGubHXu[4UhemWuYYTpeoUhfG9iY3;ueJJwdA>? M4ra[VIyQDVzMEi5
HepG2 cells NVu1VoIyTnWwY4Tpc44h[XO|YYm= MUWxNEB2VQ>? NXK5OpJtOjRiaB?= MoTIVoVlfWO2aX;uJI9nKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbY5{fWyrbj3y[ZNqe3SjboSgbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidV2gZYZ1\XJiMkSgbJJ{KGK7IHfseYNwe2Vib4jp[IF{\SCvZYToc4QhcW5icILld4Vv[2Vib3[gNlIvOiCvTTDv[kBodHWlb4Pl MYiyN|AzPTJ2NB?=
HepG2 cells NU[5cIJDTnWwY4Tpc44h[XO|YYm= MXixNEB2VQ>? NEn0cm8zPCCq NFzp[5BT\WS3Y4Tpc44hd2ZiZ3z1Z49{\SClb37zeY1xfGmxbjDpckBqdnO3bHnuMZJme2m|dHHueEBpfW2jbjDI[ZBIOiClZXzsd{BifCBzMDD1UUBi\nSncjCyOEBpenNiYomg[4x2[2:|ZTDvfIll[XOnIH3leIhw\CCrbjDwdoV{\W6lZTDv[kAxNjFidV2gc4YhcW6|dXzpci=> MUGyN|AzPTJ2NB?=
THP1 cells NI[1W4JHfW6ldHnvckBie3OjeR?= Mkn6NVAxKHWP MVOzJIhzew>? MlPqWJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCqdX3hckBVUFBzIHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJGxRWy2rbnT1Z4VlKE2FUEGgcXJPSSCneIDy[ZN{cW:wIHH0JFExOCC3TTDwdoVqdmO3YnH0[YQh\m:{IEOgbJJ{KHC{aX;yJJRwKEySUzDjbIFtdGWwZ3WgcYVie3W{ZXSgZYZ1\XJiMUigbJJ{KGK7IGLUMXBEWiCjbnHsfZNqeyC{ZXzheIl3\SC2bzD1cpRz\WG2ZXSgZ49vfHKxbB?= M3e3UFIzQTN2NUO3
THP1 cells M3;RW2Z2dmO2aX;uJIF{e2G7 M{GzT|ExOCC3TR?= MVizJIhzew>? MVXUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJIlvKGi3bXHuJHRJWDFiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gUHBUNWmwZIXj[YQhUUx4IH3SUmEh\XiycnXzd4lwdiCjdDCxNFAhfU1icILlbY5kfWKjdHXkJIZweiB|IHjyd{BxemmxcjD0c{BNWFNiY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDF6IHjyd{BjgSCUVD3QR3Ih[W6jbInzbZMhemWuYYTpeoUhfG9idX70doVifGWmIHPvcpRzd2x? NYqybVFTOjJ7M{S1N|c>
HepG2 cells M1zrd2Z2dmO2aX;uJIF{e2G7 NWrVcXVNXHKjboPhZ5RqfmG2aX;uJI9nKEeDTESt[pV{\WRiUGDBVodidW2jIHzp[4Fv\CCkaX7kbY5oKGSxbXHpckB1emGwc3\lZ5Rm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5zIN88US=> MWOyNlk{PDV|Nx?=
HepG2 cells MlvDSpVv[3Srb36gZZN{[Xl? MYqyNEBp MWXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFfBUFQu\nW|ZXSgVHBCWmejbX3hJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gTIVxTzJiY3XscJMh[W[2ZYKgNlAhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOiEQvF2= MYeyNlA5OTl|Mh?=
BL21 DE3 cells NXrm[oxqTnWwY4Tpc44h[XO|YYm= Mn:wSIl{eGyjY3Xt[Y51KG:oIGuzTH1zd3OrZ3zpeIF7d26nIH\yc40hVi22ZYLtbY5idCCKaYOteIFo\2WmIHj1cYFvKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKEW|Y3jldolkcGmjIHPvcIkhSkx{MTDESVMh[2WubIOgZpkhe2OrboTpcIxifGmxbjDwdo95cW2rdImgZZN{[XluIFvpQVAvODd2IN88US=> MkLlNlIxQDF7M{K=
human L02 cells NEnJdoVHfW6ldHnvckBie3OjeR?= M1;Td2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4hcHWvYX6gUFAzKGOnbHzzJINwNWW6cILld5NqdmdicFfMN{1UXjRyLVfBUFQh[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDiZZNm\CC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD65JO69VQ>? NWm5eGo6OjNzOE[zNFc>
HepG2 cells MUjGeY5kfGmxbjDhd5NigQ>? MmfnNlAhcA>? NUDRb2V6XHKjboPhZ5RqfmG2aX;uJI9nKEeDTESt[pV{\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCzPUDPxE1? NXKwUVNwOjNzN{GwOFU>
HEK293 cells NFzOSG9HfW6ldHnvckBie3OjeR?= MXuxNEDPxE1? MlTOWJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBCWDJvUGDSSUBifCBzMDD1UUBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= MnzsNlMzPzN3MUm=
HEK293 cells NECzc41HfW6ldHnvckBie3OjeR?= Mln0RYdwdmm|dDDheEBpfW2jbjDQVGFT\2GvbXGgUGJFKGW6cILld5Nm\CCrbjDoeY1idiCKRVuyPVMh[2WubIOgZ491emGwc3\lZ5Rm\CC5aYToJGdCVDRvTIXjJIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlAxPCEQvF2= NFjQeJgzOzJ6Nke4Oy=>
HEK293 cells NV;XbJVnTnWwY4Tpc44h[XO|YYm= MVmyOEBp MUnUdoFve2GldHn2ZZRqd25ib3[gS2FNPCCGQlSt[pV{\WRiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6xJO69VQ>? MlnENlMzQTR6M{C=
HEK293 cells NXfiZYd6TnWwY4Tpc44h[XO|YYm= NXfkZoRxPDhiaILz M1jLcWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZ491emGwc3\lZ5Rm\CC5aYToJHBRWkW6ND3UT{1tfWNiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iCudXPp[oVz[XOnIHHjeIl3cXS7IH3lZZN2emWmIHHmeIVzKDR6IHjyd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;NEOuO|Eh|ryP Mmq5NlMzPjV6NES=
HepG2 cells MXPGeY5kfGmxbjDhd5NigQ>? Ml;URYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LX\1d4VlKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMTFOwG0> NX\XUodDOjN3MEKyNVI>
HepG2 cells NV3jNplXTnWwY4Tpc44h[XO|YYm= NVPX[3R{SWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MYZ2e2WmIGDQRXJo[W2vYTDNOFY{SSCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODB{IN88US=> MnjhNlM2ODJ{MUK=
L6 cells MkH5SpVv[3Srb36gZZN{[Xl? NWn4b2NWOjRiaILz MV\JcoR2[3Srb36gc4Yh\2y3Y3;z[UB2eHSja3WgbY4hemG2IFy2JINmdGy|IID1cJNm\CC5aYToJGMyPC2mZX;4fUBodHWlb4PlJIFnfGW{IEK0JIhzeyCrbjDwdoV{\W6lZTDv[kBqdnO3bHnuMEBGSzVyPUSuOFkh|ryP Ml\BNlM6QTJ6NkK=
L6 cells M1rGeWZ2dmO2aX;uJIF{e2G7 NFXr[IcyPiCqcoO= MWPJcoNz\WG|ZTDpckAzNVt|SG2t[IVwgHmpbIXjc5NmKHWydHHr[UBqdiC{YYSgUFYh[2WubIOgZYZ1\XJiMU[gbJJ{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoch[W6jbInzbZMtKEWFNUC9OE45KM7:TR?= NH\ZNWczPDhzM{ezPC=>
DU145 cells NV32c45DS3m2b4TvfIlkcXS7IHHzd4F6 NGHScGg1QCCqcoO= M{n3bGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFXDOVA:OTZizszN MWqyOFk6PjF2Mx?=
PC3 cells NHjNSYJEgXSxdH;4bYNqfHliYYPzZZk> M3HhSVQ5KGi{cx?= NUHqZWRyS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFXDOVA:OjBwMzFOwG0> MmPrNlQ6QTZzNEO=
MDA-MB-231 cells MVPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MlzWNlQhcHK| MnG4S5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gUWRCNU2ELUKzNUBk\WyuczDh[pRmeiB{NDDodpMh[nliTWTUJIF{e2G7LDDFR|UxRTVwMkOg{txO MXOyOVI4QDJ|Nh?=
HEK293 cells MXTGeY5kfGmxbjDhd5NigQ>? NHvoOlZC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCxJO69VQ>? MlW2NlU{ODV4OEi=
HepG2 cells Mn[5SpVv[3Srb36gZZN{[Xl? MUCyNEBpenN? MY\UdoFve2GldHn2ZZRqd25ib3[gVHBCWiC2cnHud4Zm[3SnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjCyNEBpenNiYomgVHBCWi2udXPp[oVz[XOnIHHzd4F6NCCHQ{WwQVEvPiEQvF2= NYH0OpNuOjV2M{ezNFQ>
HEK293 cells MlvqSpVv[3Srb36gZZN{[Xl? NVLKenNuOjRiaILz MnrPWJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgbY5kfWKjdHXkJIZweiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 MYOyOVQ1OjN{Mh?=
HepG2 cells MV;GeY5kfGmxbjDhd5NigQ>? MVLB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFfBUFQuWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFM6KM7:TR?= M1HXU|I2PDZ{Mkix
HEK293 cells MnS4SpVv[3Srb36gZZN{[Xl? MVGyOEBpenN? NVvPXFY2SWexbnnzeEBi[3Srdnn0fUBifCCvb4Xz[UBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bkdy2neIDy[ZN{cW6pIIfpeIghT2GuNDDy[ZBwenSncjD2[YN1d3JiYX\0[ZIhOjRiaILzJIJ6KGS3YXytcJVkcW[ncnHz[UBz\XCxcoTldkBie3OjeTygSWM2OD1yLkCzJO69VQ>? M1;kcFI1QTV3OEi5
HepG2 cells MUPGeY5kfGmxbjDhd5NigQ>? NYm0OpU5OjBiaILz MWfB[49vcXO2IHHjeIl3cXS7IHH0JGdCVDRvRF7BJIJqdmSrbneg[I9u[WmwIH\1d4VlKGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJIh2dWGwIFjldGczKGOnbHzzJIF{e2W|c3XkJIF{KHKnY3XweI9zKHS{YX7zZYN1cX[jdHnvckBqdmO3YnH0[YQh\m:{IEKwJIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xPCEQvF2= M2Th[lI2PDl5MUOy
HepaR cells NUL6VFBJTnWwY4Tpc44h[XO|YYm= MnHnNUBl[Xl? Mn6yRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hUE2JQ2OyJIdmdmViZYjwdoV{e2mxbjDheEAyKHWPIHnuZ5Vj[XSnZDDmc5IhOSCmYYmgZpkheXWjboTpeIF1cX[nIGDDVkBu\XSqb3SgdoVt[XSrdnWgeI8hfW62cnXheIVlKGOxboTyc4w> MVmyOVQ6PzF|Mh?=
HepaR cells M3rmNGZ2dmO2aX;uJIF{e2G7 NIXpN2syKHWP NX7CenBOOSCmYYm= M2TlXGFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincHHSJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEGQR2DUUFQh\2WwZTDlfJBz\XO|aX;uJIF1KDFidV2gbY5kfWKjdHXkJIZweiBzIHThfUBjgSCzdXHueIl1[XSrdnWgVGNTKG2ndHjv[EBz\WyjdHn2[UB1dyC3boTy[YF1\WRiY3;ueJJwdA>? MljINlU1QTdzM{K=
HepaR cells NVL0TZV[TnWwY4Tpc44h[XO|YYm= NVf0Z5I2OSC3TR?= MYqxJIRigQ>? MnjLRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hTkGEUEGg[4Vv\SCneIDy[ZN{cW:wIHH0JFEhfU1iaX7jeYJifGWmIH\vdkAyKGSjeTDifUByfWGwdHn0ZZRqfmViUFPSJI1mfGixZDDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> NHfo[YYzPTR7N{GzNi=>
HEK293 cells NX;3O2VyTnWwY4Tpc44h[XO|YYm= M{jxfVExKM7:TR?= MVGyOEBpenN? MmHaWJJidnOjY4TpeoF1cW:wIH;mJHBRSVJvZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIF1KDFyIIXNJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> M4XqdlI1QDlyMEmw
C2C12 cells MlrVSpVv[3Srb36gZZN{[Xl? NF;GVGM{OCEQvF2= NHT1WWUzKGh? NF;1b5RKdmS3Y4Tpc44hd2ZiMj3k[Y95gS2dM1jdMYdtfWOxc3WgeZB1[WunIHnuJI1wfXOnIFOyR|EzKGOnbHzzJIF1KDNyIIXNJIFnfGW{IEKgbJJ{KGK7IHzpdZVq\CC|Y3nueIltdGG2aX;uJINwfW62aX7nJIFv[Wy7c3nz M{fFSVI2QDN3NUO3
MCF7 cells MnvzSpVv[3Srb36gZZN{[Xl? NFXON4EyPiCq NHzER5lC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUB1emGwc3\lZ5Rm\CCrbjDoeY1idiCPQ1[3JINmdGy|IHHmeIVzKDF4IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wPFch|ryP MlzkNlYzOjZ2OUC=
HEK293 cells M{XZO2Z2dmO2aX;uJIF{e2G7 NXrVW2Y5OTBizszN M4\tcVI1KGh? NYLTVXdCSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiKIXub45wf25ib4Lp[4lvMSCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCjdDCxNEB2VSCrbnP1ZoF1\WRiZn;yJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? M2n1b|I3Ozh2Mki2

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID